Plus Therapeutics News

Plus Therapeutics | 424B3: Prospectus

Nov 1 20:32

Plus Therapeutics | 8-K: Current report

Nov 1 20:27

Plus Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Oct 5 04:15

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hawkins Richard J

Sep 17 19:04

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hawkins Richard J

Sep 16 19:01

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Petersen Greg

Sep 13 18:11

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Clowes Howard

Sep 13 18:07

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sims Andrew John Hugh MacIntyre

Sep 13 04:36

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Clowes Howard

Sep 13 04:36

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lenk Robert P

Sep 13 04:36

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HEDRICK MARC H

Sep 13 04:36

Plus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HEDRICK MARC H

Sep 11 18:06

Plus Therapeutics | 424B3: Prospectus

Sep 7 04:55

Plus Therapeutics | 8-K: Current report

Sep 7 04:50

Plus Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 24 04:37

Plus Therapeutics | 424B3: Prospectus

Aug 16 04:58

Plus Therapeutics | 8-K: Current report

Aug 16 04:52

Plus Therapeutics | 424B3: Prospectus

Aug 15 04:51

Plus Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 15 04:36

Plus Therapeutics | 8-K: Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 15 04:11